Skip to main content
Erschienen in: International Urogynecology Journal 11/2013

01.11.2013 | Original Article

Estrogen-related genome-based expression profiling study of uterosacral ligaments in women with pelvic organ prolapse

verfasst von: Yeo Jung Moon, Sang Wook Bai, Chan-Young Jung, Chul Hoon Kim

Erschienen in: International Urogynecology Journal | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The aim of the study was to identify the differential expression of estrogen-related genes that may be involved in the menopause and pelvic organ prolapse (POP) using microarray analysis.

Methods

An age, parity, and menopausal status-matched case–control study with 12 POP patients and 5 non-POP patients was carried out. The study was conducted from January to December 2010 at Yonsei University, Severance Hospital. We examined microarray gene expression profiles in uterosacral ligaments (USLs) from POP and non-POP patients. Total RNA was extracted from USL samples to generate labeled cDNA, which was hybridized to microarrays and analyzed for the expression of 44,049 genes. We identified differentially expressed genes and performed functional clustering. After clustering, we focused on transcriptional response and signal transduction gene clusters, which are associated with estrogen, and then validated the changes of gene expression levels observed with the microarray analysis using quantitative polymerase chain reaction (qPCR).

Results

The data from the microarray analysis using more than a 1.5-fold change with p value <0.05 resulted in 143 upregulated genes and 87 downregulated genes. Of 59 genes identified to be associated with signal transduction and transcription, 4 genes were chosen for qPCR that have been classified to be associated with estrogen. We found that estrogen receptor-related receptor-α (ERRα) was downregulated and that the expression of death-associated protein kinase 2 (DAPK 2), signal-transducing adaptor protein-2 (STAP-2), and interleukin (IL)-15 were upregulated.

Conclusions

We found four differentially expressed genes by microarray analysis that may account for the way in which changes in estrogen level affect POP pathophysiology.
Literatur
1.
Zurück zum Zitat Wu JM, Hundley AF, Fulton RG, Myers ER (2009) Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet Gynecol 114(6):1278–1283PubMedCrossRef Wu JM, Hundley AF, Fulton RG, Myers ER (2009) Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet Gynecol 114(6):1278–1283PubMedCrossRef
2.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506PubMedCrossRef Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506PubMedCrossRef
3.
4.
Zurück zum Zitat DeLancey JO (1992) Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol 166(6 Pt 1):1717–1724, discussion 1724–1718PubMedCrossRef DeLancey JO (1992) Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol 166(6 Pt 1):1717–1724, discussion 1724–1718PubMedCrossRef
5.
Zurück zum Zitat Moon YJ, Choi JR, Jeon MJ, Kim SK, Bai SW (2011) Alteration of elastin metabolism in women with pelvic organ prolapse. J Urol 185(5):1786–1792PubMedCrossRef Moon YJ, Choi JR, Jeon MJ, Kim SK, Bai SW (2011) Alteration of elastin metabolism in women with pelvic organ prolapse. J Urol 185(5):1786–1792PubMedCrossRef
6.
Zurück zum Zitat Suzme R, Yalcin O, Gurdol F, Gungor F, Bilir A (2007) Connective tissue alterations in women with pelvic organ prolapse and urinary incontinence. Acta Obstet Gynecol Scand 86(7):882–888PubMedCrossRef Suzme R, Yalcin O, Gurdol F, Gungor F, Bilir A (2007) Connective tissue alterations in women with pelvic organ prolapse and urinary incontinence. Acta Obstet Gynecol Scand 86(7):882–888PubMedCrossRef
7.
Zurück zum Zitat Sze EH, Hobbs G (2012) A prospective cohort study of pelvic support changes among nulliparous, multiparous, and pre- and post-menopausal women. Eur J Obstet Gynecol Reprod Biol 160(2):232–235PubMedCrossRef Sze EH, Hobbs G (2012) A prospective cohort study of pelvic support changes among nulliparous, multiparous, and pre- and post-menopausal women. Eur J Obstet Gynecol Reprod Biol 160(2):232–235PubMedCrossRef
8.
Zurück zum Zitat Jackson S, James M, Abrams P (2002) The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 109(3):339–344PubMedCrossRef Jackson S, James M, Abrams P (2002) The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 109(3):339–344PubMedCrossRef
9.
Zurück zum Zitat Hundley AF, Yuan L, Visco AG (2008) Gene expression in the rectus abdominus muscle of patients with and without pelvic organ prolapse. Am J Obstet Gynecol 198(2):220.e221–220.e227CrossRef Hundley AF, Yuan L, Visco AG (2008) Gene expression in the rectus abdominus muscle of patients with and without pelvic organ prolapse. Am J Obstet Gynecol 198(2):220.e221–220.e227CrossRef
10.
Zurück zum Zitat Brizzolara SS, Killeen J, Urschitz J (2009) Gene expression profile in pelvic organ prolapse. Mol Hum Reprod 15(1):59–67PubMedCrossRef Brizzolara SS, Killeen J, Urschitz J (2009) Gene expression profile in pelvic organ prolapse. Mol Hum Reprod 15(1):59–67PubMedCrossRef
11.
Zurück zum Zitat Tseng LH, Chen I, Lin YH, Chen MY, Lo TS, Lee CL (2010) Genome-based expression profiles study for the pathogenesis of pelvic organ prolapse: an array of 33 genes model. Int Urogynecol J 21(1):79–84PubMedCrossRef Tseng LH, Chen I, Lin YH, Chen MY, Lo TS, Lee CL (2010) Genome-based expression profiles study for the pathogenesis of pelvic organ prolapse: an array of 33 genes model. Int Urogynecol J 21(1):79–84PubMedCrossRef
12.
Zurück zum Zitat Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C et al (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935–948PubMedCrossRef Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C et al (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935–948PubMedCrossRef
13.
Zurück zum Zitat Goldstein SR, Nanavati N (2002) Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol 187(3):521–527PubMedCrossRef Goldstein SR, Nanavati N (2002) Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol 187(3):521–527PubMedCrossRef
14.
Zurück zum Zitat Chen H, Chung Y, Lin W, Chen W, Tsai F, Tsai C (2008) Estrogen receptor alpha polymorphism is associated with pelvic organ prolapse risk. Int Urogynecol J Pelvic Floor Dysfunct 19(8):1159–1163PubMedCrossRef Chen H, Chung Y, Lin W, Chen W, Tsai F, Tsai C (2008) Estrogen receptor alpha polymorphism is associated with pelvic organ prolapse risk. Int Urogynecol J Pelvic Floor Dysfunct 19(8):1159–1163PubMedCrossRef
15.
Zurück zum Zitat Skala CE, Petry IB, Albrich S, Puhl A, Naumann G, Koelbl H (2011) The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse. Int Urogynecol J Pelvic Floor Dysfunct 22(6):705–712CrossRef Skala CE, Petry IB, Albrich S, Puhl A, Naumann G, Koelbl H (2011) The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse. Int Urogynecol J Pelvic Floor Dysfunct 22(6):705–712CrossRef
16.
Zurück zum Zitat Bonnelye E, Aubin JE (2005) Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. J Clin Endocrinol Metab 90(5):3115–3121PubMedCrossRef Bonnelye E, Aubin JE (2005) Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. J Clin Endocrinol Metab 90(5):3115–3121PubMedCrossRef
17.
Zurück zum Zitat Bonnelye E, Merdad L, Kung V, Aubin JE (2001) The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153(5):971–984PubMedCrossRef Bonnelye E, Merdad L, Kung V, Aubin JE (2001) The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153(5):971–984PubMedCrossRef
18.
Zurück zum Zitat Verma S, Hiby SE, Loke YW, King A (2000) Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 62(4):959–968PubMedCrossRef Verma S, Hiby SE, Loke YW, King A (2000) Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 62(4):959–968PubMedCrossRef
19.
Zurück zum Zitat Chegini N, Ma C, Roberts M, Williams RS, Ripps BA (2002) Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J Reprod Immunol 56(1–2):93–110PubMedCrossRef Chegini N, Ma C, Roberts M, Williams RS, Ripps BA (2002) Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J Reprod Immunol 56(1–2):93–110PubMedCrossRef
20.
Zurück zum Zitat Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H (2000) IL-15 expression at human endometrium and decidua. Biol Reprod 63(3):683–687PubMedCrossRef Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H (2000) IL-15 expression at human endometrium and decidua. Biol Reprod 63(3):683–687PubMedCrossRef
21.
Zurück zum Zitat Chen B, Wen Y, Yu X, Polan ML (2005) Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones? Am J Obstet Gynecol 192(5):1605–1613PubMedCrossRef Chen B, Wen Y, Yu X, Polan ML (2005) Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones? Am J Obstet Gynecol 192(5):1605–1613PubMedCrossRef
22.
Zurück zum Zitat Lin Y, Hupp TR, Stevens C (2010) Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death. FEBS J 277(1):48–57PubMedCrossRef Lin Y, Hupp TR, Stevens C (2010) Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death. FEBS J 277(1):48–57PubMedCrossRef
23.
Zurück zum Zitat Liu SB, Zhang N, Guo YY, Zhao R, Shi TY, Feng SF et al (2012) G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci 32(14):4887–4900PubMedCrossRef Liu SB, Zhang N, Guo YY, Zhao R, Shi TY, Feng SF et al (2012) G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci 32(14):4887–4900PubMedCrossRef
24.
Zurück zum Zitat Levy D, Plu-Bureau G, Decroix Y, Hugol D, Rostene W, Kimchi A et al (2004) Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis. Clin Cancer Res 10(9):3124–3130PubMedCrossRef Levy D, Plu-Bureau G, Decroix Y, Hugol D, Rostene W, Kimchi A et al (2004) Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis. Clin Cancer Res 10(9):3124–3130PubMedCrossRef
25.
Zurück zum Zitat Tanaka T, Bai T, Yukawa K (2010) Death-associated protein kinase is essential for the survival of various types of uterine cancer cells. Int J Oncol 37(4):1017–1022PubMedCrossRef Tanaka T, Bai T, Yukawa K (2010) Death-associated protein kinase is essential for the survival of various types of uterine cancer cells. Int J Oncol 37(4):1017–1022PubMedCrossRef
26.
Zurück zum Zitat Takacs P, Nassiri M, Gualtieri M, Candiotti K, Medina CA (2009) Uterosacral ligament smooth muscle cell apoptosis is increased in women with uterine prolapse. Reprod Sci 16(5):447–452PubMedCrossRef Takacs P, Nassiri M, Gualtieri M, Candiotti K, Medina CA (2009) Uterosacral ligament smooth muscle cell apoptosis is increased in women with uterine prolapse. Reprod Sci 16(5):447–452PubMedCrossRef
27.
Zurück zum Zitat Sekine Y, Ikeda O, Mizushima A, Ueno Y, Muromoto R, Yoshimura A et al (2012) STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis. Oncogene 31:(40)4384–4396PubMedCrossRef Sekine Y, Ikeda O, Mizushima A, Ueno Y, Muromoto R, Yoshimura A et al (2012) STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis. Oncogene 31:(40)4384–4396PubMedCrossRef
28.
Zurück zum Zitat Ikeda O, Sekine Y, Mizushima A, Nakasuji M, Miyasaka Y, Yamamoto C et al (2010) Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells. J Biol Chem 285(49):38093–38103PubMedCrossRef Ikeda O, Sekine Y, Mizushima A, Nakasuji M, Miyasaka Y, Yamamoto C et al (2010) Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells. J Biol Chem 285(49):38093–38103PubMedCrossRef
29.
Zurück zum Zitat Visco AG, Yuan L (2003) Differential gene expression in pubococcygeus muscle from patients with pelvic organ prolapse. Am J Obstet Gynecol 189(1):102–112PubMedCrossRef Visco AG, Yuan L (2003) Differential gene expression in pubococcygeus muscle from patients with pelvic organ prolapse. Am J Obstet Gynecol 189(1):102–112PubMedCrossRef
Metadaten
Titel
Estrogen-related genome-based expression profiling study of uterosacral ligaments in women with pelvic organ prolapse
verfasst von
Yeo Jung Moon
Sang Wook Bai
Chan-Young Jung
Chul Hoon Kim
Publikationsdatum
01.11.2013
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 11/2013
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-013-2124-9

Weitere Artikel der Ausgabe 11/2013

International Urogynecology Journal 11/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.